When it comes to helping people “get in the mood”, pharmaceutical companies are largely biased. Most of the products on the market target men, leaving women out in the cold…DRY. Dry ass cold. We’ve all heard of the little “blue pill” men take when they wanna get their freak on. But we’ve yet to come across something for women…until now.
The FDA has finally approved a drug called Addyi after rejecting it back in 2010 and 2013.
So what does the pink pill do? Well it targets the neurotransmitters that are responsible for sexual desire in women. Those include dopamine and norepinephrine.
Via The New York Times:
“I think this is going to change the conversation that’s taking place in medical offices across the country,” she said, much as the 1998 approval of Viagra made it acceptable for men to talk about erectile dysfunction.
This life saver will be used to treat sexual dysfunction in premenopausal women.
This is a huge milestone considering that this is the first product of its kind. To be effective, the pill will have to be taken daily. Like most good things, these little babies come at a price. Patients can expect to pay anywhere from 30-75 bucks a month for their prescriptions.
“This is the biggest breakthrough for women’s sexual health since the pill,” said Sally Greenberg, executive director of the National Consumers League.
This scares me though…Addyi’s label has a boxed warning — the strongest kind — saying the drug should not be used by those who drink alcohol, since that can increase the risk of severely low blood pressure and fainting. It is also not to be used with certain other drugs and by people with liver impairment. No liquor? Well isn’t that when people have the most sex? LOL
I kid. I kid. But seriously, who wants to be fainting all willy nilly?
But regardless of the crazy side effects, Addyi hits the market on October 17th of this year.
So what do you think ladies? Is this exciting news or what?